Medscape (3/5, Otto, Subscription Publication) reported, “Patients consider the risk of cancer and menopause, as well as other factors, when making decisions about ovarian cancer prevention surgery, according to a small study.” Researchers “interviewed 24 premenopausal women with BRCA mutations who were considering prophylactic surgery,” and “responses showed that women who prioritized cancer risk reduction opted for risk-reducing salpingo-oophorectomy (RRSO), while those who were more concerned about the effects of surgical menopause opted for risk-reducing early salpingectomy with delayed oophorectomy (RRESDO).” The findings were published in the Journal of Medical Genetics.